Open-uri20160108-3-aw1pd5_thumb

Priti Patnaik

Independent Journalist & Researcher

Geneva, Swizterland

Priti Patnaik

I am a financial journalist, and a researcher in international development.

Geneva. New York. New Delhi.

Open-uri20190208-4-kwgcee_profile

What the recent discussions on access to medicines at WHO’s Executive Board tell us

When the Tedros administration assumed office in 2017, there was some apprehension in certain sections of the global health community, about the extent to which WHO would protect and pursue the contentious issue of access to medicines. Less than two years on, one can be fairly convinced that this administration is serious in leading from the front and some might even say, successfully walking the tightrope – for now.
International Health Policies Link to Story
Open-uri20190208-4-19868va_profile

WHO Report Flags Distortion of Investment and Innovation in Cancer Research

Geneva: High prices of cancer drugs hurting desperate patients have caught the attention of policymakers everywhere. But do high prices of medicines that provide huge financial returns to pharmaceutical companies also distort innovation? A new cancer report by World Health Organisation (WHO) has both countries and the pharma industry debating on just how much profit cancer drugs generate for pharmaceutical companies.
The Wire Link to Story
Open-uri20180204-4-vw8yhh_profile

Battle for Access to Medicines Takes Centre Stage at WHO

From prohibitive cancer drugs to making resources available to fight microbial drug resistance, or getting access to timely diagnostics – access issues are the cornerstone for equitable health systems worldwide.
The Wire, India Link to Story
Open-uri20180201-4-1b6p7cp_profile

WHO Priorities Likely to Be Constrained by Finances

Irrespective of all the ambitions for the future and earnest intentions to reform the administration, ultimately it will be financing that will dictate how far WHO can go.
The Wire, India Link to Story
Open-uri20180119-4-1xosyvy_profile

WHO Gets to Work: 2018 a Litmus Test for New Team

Ambitious priorities, strained budgets and a changing political order dominate the World Health Organisation’s upcoming annual executive board meet in Geneva
The Wire, India Link to Story
Open-uri20171203-4-dycq97_profile

Global Fund Elections: American influence in Global Health Politics

Peter Sands was elected the executive director of the financing organisation even though he did not have American support, perhaps indicating the country’s waning importance.
The Wire, India Link to Story
Open-uri20171004-4-7d8f8t_profile

A New Administration Settles in at the WHO

A new team and new priorities are taking shape at WHO, but will the new director general engage with challenging issues or maintain status quo?
The Wire Link to Story
Open-uri20170611-4-1lm9fla_profile

Challenges Awaiting the Next WHO Chief

The 70th World Health Assembly saw the election of a new leader, a strong resolution on battling cancer and unexpected coalitions around access to medicines, among others
The Wire, India Link to Story
Open-uri20170710-4-lz05vm_profile

The Summit on Neglected Tropical Diseases

The Geneva Commitment on Neglected Tropical Diseases: Key Takeaways
Open-uri20170331-4-1yli74f_profile

WHO is Electing a New Leader. Here’s What’s at Stake

A look at member states’ considerations, candidates plans for the future of global public health management and contemporary issues for the WHO.
The Wire, India Link to Story
Open-uri20161012-3-zpimvl_profile

US’s Inconsistent Policies on Pharma Could Compromise Global Access to Medication

A recently released UN report highlights international “policy incoherence” on medication, but the US has denounced its findings, signalling its unwillingness to institute reforms.
The Wire, India Link to Story
Open-uri20160920-3-2vfne6_profile

Deconstructing India’s Model Bilateral Investment Treaty

India was one of the most sued countries in 2015. Will the country’s new model bilateral investment treaty attract and safeguard foreign investment more effectively? India’s efforts to attract and safeguard foreign investment while protecting public interest will be keenly watched in the midst of reforms in international investment agreements.
The Wire, India Link to Story

About

Priti Patnaik

I am a financial journalist who also works in international development in Geneva.

During my 15 years in journalism, I have worked in Geneva, New York City and New Delhi. Outside of journalism, I have had stints at a trade law firm specializing in WTO disputes and at a UN public health organization in Geneva.

I have reported on public finance, India’s monetary policy and the financial sector, for the biggest economic newspapers in India, based out of Delhi. In New York, I reported on debt and bankruptcy in the immediate aftermath of the financial crises in different newsrooms. In Switzerland, I write on issues of banking secrecy, illicit financial flows, bilateral trade deals, intellectual property and the pharmaceutical industry.

I hold a master's degree in Business & Economic Reporting from New York University (2010) and a master's in Development Studies from The Graduate Institute in Geneva (2013). I also have a PG Diploma in broadcast journalism from the Asian College of Journalism, Chennai (2003). I graduated with a bachelor's degree in science, majoring in microbiology, genetics and chemistry from Osmania University, Hyderabad (2002).

I look forward to opportunities in, not limited to, corporate responsibility, public health, environment and trade - areas where science, economics and law come together.

I am keen on opportunities that will not only utilize my journalistic skills in writing, editing and investigations but also give me scope to do development-related work.